Birth defects after early pregnancy use of antithyroid drugs: A Danish nationwide study

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 11, 2013, Pages 4373-4381

  Andersen, Stine Linding ^a   Olsen, Jørn ^b   Wu, Chun Sen ^b   Laurberg, Peter ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTITHYROID AGENT; CARBIMAZOLE; PROPYLTHIOURACIL; THIAMAZOLE;

ADULT; ARTICLE; BIRTH DEFECT; CHILD; CHOANA ATRESIA; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; DISEASE REGISTRY; ESOPHAGUS ATRESIA; FACE MALFORMATION; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; NECK MALFORMATION; OMPHALOCELE; OMPHALOMESENTERIC DUCT ANOMALY; POPULATION RESEARCH; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; SKIN APLASIA; URINARY TRACT MALFORMATION;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTITHYROID AGENTS; CARBIMAZOLE; DENMARK; FEMALE; HUMANS; HYPERTHYROIDISM; INFANT, NEWBORN; MALE; METHIMAZOLE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PREVALENCE; PROPYLTHIOURACIL;

EID: 84887423969     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2831     Document Type: Article

References (40)

1. Mestman JH. Hyperthyroidism in pregnancy. Best Pract Res Clin Endocrinol Metab. 2004;18: 267-288.
2. Sheffield JS, Cunningham FG. Thyrotoxicosis and heart failure that complicate pregnancy. Am J Obstet Gynecol. 2004;190: 211-217.
3. Andersen SL, Olsen J, Wu CS, Laurberg P. Low birth weight in children born to mothers with hyperthyroidism and high birth weight in hypothyroidism, whereas preterm birth is common in both conditions: A Danish national hospital register study. Eur Thyroid J. 2013;2: 135-144.
4. ZimmermanD. Fetal and neonatal hyperthyroidism. Thyroid. 1999; 9: 727-733.
5. Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352: 905-917.
6. CassinaM,DonàM,Di Gianantonio E, ClementiM.Pharmacologic treatment of hyperthyroidism during pregnancy. Birth Defects Res A Clin Mol Teratol. 2012;94: 612-619.
7. Mortimer RH, Cannell GR, Addison RS, Johnson LP, Roberts MS, Bernus I. Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab. 1997; 82: 3099-3102.
8. Wing DA, Millar LK, Koonings PP, Montoro MN, Mestman JH. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol. 1994;170: 90-95.
9. Momotani N,NohJY, Ishikawa N, Ito K. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. J Clin Endocrinol Metab. 1997;82: 3633-3636.
10. Bowman P, Osborne NJ, Sturley R, Vaidya B. Carbimazole embryopathy: Implications for the choice of antithyroid drugs in pregnancy. QJM. 2012;105: 189-193.
11. Taylor PN, Vaidya B. Side effects of anti-thyroid drugs and their impact on the choice of treatment for thyrotoxicosis in pregnancy. Eur Thyroid J. 2012;1: 176-185.
12. Foulds N, Walpole I, Elmslie F, Mansour S. Carbimazole embryopathy: An emerging phenotype. Am J Med Genet A. 2005;132A: 130-135.
13. Karlsson FA, Axelsson O, Melhus H. Severe embryopathy and exposure to methimazole in early pregnancy. J Clin Endocrinol Metab. 2002;87: 947-949.
14. Rosenfeld H, Ornoy A, Shechtman S, Diav-Citrin O. Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil:Acontrolled cohort study. Br J Clin Pharmacol. 2009;68: 609-617.
15. Bowman P, Vaidya B. Suspected spontaneous reports of birth defects in the UK associated with the use of carbimazole and propylthiouracil in pregnancy. J Thyroid Res. 2011;2011:235130.
16. Yoshihara A, Noh J, Yamaguchi T, et al. Treatment of Graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab. 2012;97: 2396-2403.
17. Alamdari S, Azizi F, Delshad H, Sarvghadi F, Amouzegar A, Mehran L. Management of hyperthyroidism in pregnancy: Comparison of recommendations of American thyroid association and Endocrine society. J Thyroid Res. 2013;2013:878467.
18. Glinoer D, Cooper DS. The propylthiouracil dilemma. Curr Opin Endocrinol Diabetes Obes. 2012;19: 402-407.
19. Löllgen RM, Calza AM, Schwitzgebel VM, Pfister RE. Aplasia cutis congenita in surviving co-twin after propylthiouracil exposure in utero. J Pediatr Endocrinol Metab. 2011;24: 215-218.
20. Cheron RG, Kaplan MM, Larsen PR, Selenkow HA, Crigler JF. Neonatal thyroid function after propylthiouracil therapy for maternal Graves' disease. N Engl J Med. 1981;304: 525-528.
21. Benavides VC, Mallela MK, Booth CJ, Wendler CC, Rivkees SA. Propylthiouracil is teratogenic in murine embryos. PLoS One. 2012;7:e35213.
22. van Veenendaal NR, Ulmer B, Boskovski MT, et al. Embryonic exposure to propylthiouracil disrupts left-right patterning in Xenopus embryos. FASEB J. 2013;27: 684-691.
23. Lazarus JH. Antithyroid drug treatment in pregnancy. J Clin Endocrinol Metab. 2012;97: 2289-2291.
24. Kildemoes HW, Sørensen HT, Hallas J. The Danish national prescription registry. Scand J Public Health. 2011;39: 38-41.
25. Pedersen CB, Gøtzsche H, Møller JO, Mortensen PB. The Danish civil registration system.Acohort of eight million persons. DanMed Bull. 2006;53: 441-449.
26. Knudsen LB, Olsen J. The Danish medical birth registry. Dan Med Bull. 1998;45: 320-323.
27. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. The Danish national hospital register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46: 263-268.
28. Barbero P, Valdez R, Rodríguez H, et al. Choanal atresia associated with maternal hyperthyroidism treated with methimazole: A casecontrol study. Am J Med Genet A. 2008;146A: 2390-2395.
29. Clementi M, Di Gianantonio E, Cassina M, Leoncini E, Botto LD, Mastroiacovo P; SAFE-Med Study Group. Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab. 2010;95:E337-E341.
30. Komoike Y, Matsuoka M, Kosaki K. Potential teratogenicity of methimazole: exposure of zebrafish embryos to methimazole causes similar developmental anomalies to human methimazole embryopathy. Birth Defects Res B Dev Reprod Toxicol. 2013;98: 222-229.
31. Chen CH, Xirasagar S, Lin CC, Wang LH, Kou YR, Lin HC. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: A nationwide population-based study. BJOG. 2011; 118: 1365-1373.
32. Korelitz JJ, McNally DL, Masters MN, Li SX, Xu Y, Rivkees SA. Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States. Thyroid. 2013;23: 758-765.
33. Aramaki M, Hokuto I, Matsumoto T, et al. Iridic and retinal coloboma associated with prenatal methimazole exposure. Am J Med Genet A. 2005;139A: 156-158.
34. Johnsson E, Larsson G, Ljunggren M. Severe malformations in infant born to hyperthyroid woman on methimazole. Lancet. 1997; 350:1520.
35. Yanai N, Shveiky D. Fetal hydrops, associated with maternal propylthiouracil exposure, reversed by intrauterine therapy. Ultrasound Obstet Gynecol. 2004;23: 198-201.
36. Momotani N, Ito K, Hamada N, Ban Y, Nishikawa Y, Mimura T. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol (Oxf). 1984;20: 695-700.
37. Gaist D, Sørensen HT, Hallas J. The Danish prescription registries. Dan Med Bull. 1997;44: 445-448.
38. Olesen C, Søndergaard C, Thrane N, Nielsen GL, de Jong-van den Berg L, Olsen J; EuroMAP Group. Do pregnant women report use of dispensed medications? Epidemiology. 2001;12: 497-501.
39. Larsen H, Nielsen GL, Bendsen J, Flint C, Olsen J, Sørensen HT. Predictive value and completeness of the registration of congenital abnormalities in three Danish population-based registries. Scand J Public Health. 2003;31: 12-16.
40. Laurberg P, Andersen S, Karmisholt J. Antithyroid drug therapy of Graves' hyperthyroidism: Realistic goals and focus on evidence. Expert Rev Endocrinol Metab. 2006;1: 91-102.